By Megan Wilson

Experts are divided over the impact of Medicare’s decision for Alzheimer’s drugs and other difficult diseases.

Experts are divided over the impact of Medicare’s decision for Alzheimer’s drugs and other difficult diseases.

Experts are divided over the impact of Medicare’s decision for Alzheimer’s drugs and other difficult diseases.

The outcome could swing billions of dollars in payments, influence how doctors and hospitals negotiate prices with insurers and possibly affect premiums for millions of Americans.

“A pandemic is not the time to be cutting access to doctors for patients on Medicare,” Kim Schrier, (D-Wash.) who introduced the bill along with Steven Horsford (D-Nev.), said in a statement.

“A pandemic is not the time to be cutting access to doctors for patients on Medicare,” Kim Schrier, (D-Wash.) who introduced the bill along with Steven Horsford (D-Nev.), said in a statement.

The effort to paint pharmacy benefit managers as villains has sparked a multimillion-dollar campaign to influence Democrats.

The effort to paint pharmacy benefit managers as villains has sparked a multimillion-dollar campaign to influence Democrats.

The effort to paint pharmacy benefit managers as villains has sparked a multimillion-dollar campaign to influence Democrats.